Literature DB >> 27342586

Charles Bonnet's syndrome: not only a condition of the elderly.

Heike M Elflein1, M Rudy2, K Lorenz2, K A Ponto2,3, A Scheurich4, S Pitz2.   

Abstract

PURPOSE: To investigate whether the experience of visual hallucinations, namely Charles Bonnet's syndrome, in psychologically healthy people is a phenomenon solely of elderly, visually impaired people.
METHODS: In a prospective controlled study, four groups of subjects (total 324) were formed: age ≤40 years, no visual impairment; age ≤40 years, visually impaired; age >40 years, no visual impairment; age >40 years, visually impaired. Visual impairment was defined as best-corrected visual acuity ≤0.3 (Snellen) in the better-seeing eye. Each group consisted of 81 subjects. Visual hallucinations were defined as complex visual perceptions. After ruling out psychiatric causes for visual hallucinations or medication related to the experience of visual hallucinations, affected subjects underwent a detailed interview about their visual hallucinations.
RESULTS: The prevalence of visual hallucinations among young subjects with visual impairment was 4.9 %; among the elderly visually impaired subjects, it was 6.2 %. The difference was not statistically significant. No subject without visual impairment experienced visual hallucinations.
CONCLUSIONS: Charles Bonnet's syndrome is not limited to elderly people suffering from visual impairment, though there tends to be a higher prevalence of visual hallucinations in this group.

Entities:  

Keywords:  Charles Bonnet’s syndrome; Visual hallucinations; Visual impairment

Mesh:

Year:  2016        PMID: 27342586     DOI: 10.1007/s00417-016-3387-x

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  25 in total

1.  Validating the DemTect with 18-fluoro-2-deoxy-glucose positron emission tomography as a sensitive neuropsychological screening test for early alzheimer disease in patients of a memory clinic.

Authors:  Armin Scheurich; Matthias J Muller; Thomas Siessmeier; Peter Bartenstein; Lutz G Schmidt; Andreas Fellgiebel
Journal:  Dement Geriatr Cogn Disord       Date:  2005-09-12       Impact factor: 2.959

2.  Charles Bonnet, his life, and his syndrome.

Authors:  Thomas R Hedges
Journal:  Surv Ophthalmol       Date:  2007 Jan-Feb       Impact factor: 6.048

3.  [The Charles Bonnet syndrome: visual hallucinations in the aged without mental deficiency].

Authors:  G de Morsier
Journal:  Ann Med Psychol (Paris)       Date:  1967-12       Impact factor: 0.380

4.  Hallucinations and aberrant perceptions are prevalent among the young healthy adult population.

Authors:  S García-Ptacek; D García Azorín; R Sanchez Salmador; M L Cuadrado; J Porta-Etessam
Journal:  Neurologia       Date:  2012-05-17       Impact factor: 3.109

5.  Complex visual hallucinations in the visually impaired: a structured history-taking approach.

Authors:  G Jayakrishna Menon
Journal:  Arch Ophthalmol       Date:  2005-03

6.  Charles Bonnet syndrome in leprosy; prevalence and clinical characteristics.

Authors:  N Adachi
Journal:  Acta Psychiatr Scand       Date:  1996-04       Impact factor: 6.392

7.  Visual perceptual disorders resembling the Charles Bonnet syndrome. A study of 434 consecutive patients referred to a psychogeriatric unit.

Authors:  L Norton-Willson; M Munir
Journal:  Fam Pract       Date:  1987-03       Impact factor: 2.267

8.  The Charles Bonnet syndrome: a large prospective study in The Netherlands. A study of the prevalence of the Charles Bonnet syndrome and associated factors in 500 patients attending the University Department of Ophthalmology at Nijmegen.

Authors:  R J Teunisse; J R Cruysberg; A Verbeek; F G Zitman
Journal:  Br J Psychiatry       Date:  1995-02       Impact factor: 9.319

9.  An examination of the relationship between low vision and Charles Bonnet syndrome.

Authors:  George Gilmour; Colleen Schreiber; Cecil Ewing
Journal:  Can J Ophthalmol       Date:  2009-02       Impact factor: 1.882

Review 10.  [The Charles Bonnet syndrome].

Authors:  K Podoll; M Osterheider; J Noth
Journal:  Fortschr Neurol Psychiatr       Date:  1989-02       Impact factor: 0.752

View more
  4 in total

Review 1.  The Charles Bonnet Syndrome: a Systematic Review of Diagnostic Criteria.

Authors:  Ali G Hamedani; Victoria S Pelak
Journal:  Curr Treat Options Neurol       Date:  2019-07-25       Impact factor: 3.598

Review 2.  Best practice in the management of behavioural and psychological symptoms of dementia.

Authors:  Olivier Pierre Tible; Florian Riese; Egemen Savaskan; Armin von Gunten
Journal:  Ther Adv Neurol Disord       Date:  2017-06-19       Impact factor: 6.570

3.  Screening for Charles Bonnet syndrome: Should the definition be reconsidered?

Authors:  PremNandhini Satgunam; Rebecca Sumalini; Gayathri Chittapu; Gunasree Pamarthi
Journal:  Indian J Ophthalmol       Date:  2019-07       Impact factor: 1.848

4.  Neuro-Ophthalmology at the Bedside: A Clinical Guide.

Authors:  Josef G Heckmann; Ivana Vachalova; Christoph J G Lang; Susanne Pitz
Journal:  J Neurosci Rural Pract       Date:  2018 Oct-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.